Literature DB >> 24656969

[The antibiotic policy. The Infection Committee and antimicrobial use].

José Miguel Cisneros1, M Antonia Pérez-Moreno2, M Victoria Gil-Navarro2.   

Abstract

The antibiotic policy is the set of strategies and activities undertaken to organize the antimicrobial treatment in the hospital, and achieve health outcomes for patients. The basic principles are to be direct evidence-based medicine, local epidemiology and freedom for prescribing physicians. An antibiotic policy is now more necessary than ever for clinical, epidemiological and economic reasons. The Infection Committee is responsible for the antibiotics policy in hospitals. Its functions as an advisory body to the medical directorate are the analysis of the epidemiology of the infections in the center, measures for its prevention and control, improving the appropriate use of antimicrobials, training, and knowledge production. To achieve clinical, environmental and economic policy objectives of antibiotics is not easy. The agreement of hundreds of professionals for recommendations on indications, dosage and duration of antibiotic treatment, based on the best scientific evidence and local guides is complex, but it can be done. The key to this is that the Infection Committee develops antimicrobial stewardship through a multidisciplinary team and professional leadership, and has the institutional support to ensure that the proper use of antimicrobials is a priority for the center, and therefore of each of the services involved, and that the team has the resources for antimicrobial stewardship.
Copyright © 2013 Elsevier España, S.L.U. y Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.

Entities:  

Keywords:  Antimicrobial stewardship; Antimicrobial treatment; Comisión de Infecciones; Infection Committee; Programas de optimización de antimicrobianos; Tratamiento antimicrobiano

Mesh:

Substances:

Year:  2014        PMID: 24656969     DOI: 10.1016/j.eimc.2014.01.008

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  2 in total

1.  A multidrug-resistant microorganism infection risk prediction model: development and validation in an emergency medicine population.

Authors:  Juan González Del Castillo; Agustín Julián-Jiménez; Julio Javier Gamazo-Del Rio; Eric Jorge García-Lamberechts; Ferrán Llopis-Roca; Josep María Guardiola Tey; Mikel Martínez-Ortiz de Zarate; Carmen Navarro Bustos; Pascual Piñera Salmerón; Jesús Álvarez-Manzanares; María Del Mar Ortega Romero; Martin Ruiz Grinspan; Susana García Gutiérrez; Francisco Javier Martín-Sánchez; Francisco Javier Candel González
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-13       Impact factor: 3.267

2.  Expression of chromogranin A-derived antifungal peptide CGA-N12 in Pichia pastoris.

Authors:  Xiaohua Li; Yong Fan; Qiong Lin; Jianxiong Luo; Yide Huang; Yuwang Bao; Liyu Xu
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.